Clostridium Difficile Diagnostics and Treatment Market Share Estimates, Profiles of the Leading Industry Players and Forecast to 2020 | Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc.

Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.

This report studies the Clostridium Difficile Diagnostics and Treatment Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Clostridium Difficile Diagnostics and Treatment Market analysis segmented by companies, region, type and applications in the report.

New vendors in the market are facing tough competition from established international vendors as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.

This report studies the Clostridium Difficile Diagnostics and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in the global market and splits the Clostridium Difficile Diagnostics and Treatment market by product type and applications/end industries.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1499

Market Segment by Companies, this report covers: 

Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.

This report focuses on the global Clostridium Difficile Diagnostics and Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clostridium Difficile Diagnostics and Treatment development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America.

Market Dynamics

Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, and others)
Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Benelux, Poland, Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
The Middle East and Africa (GCC, Southern Africa, North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro-and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Research methodology

To deduce market size, the report considers various aspects based on secondary research. Furthermore, data points such as product-wise split and market split by end-use. and qualitative inputs from primary respondents have been incorporated to arrive at appropriate market estimates. The forecast presented in the report assesses the total revenue generated and expected revenue contribution by the Clostridium Difficile Diagnostics and Treatment market.

When developing the market forecast, the report sizes the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Market Insights triangulates the data via different analyses based on the supply side, demand side, and other dynamics. The report not only provides a forecast in terms of CAGR but also analyses the market on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand market predictability and to identify the right opportunities. 

Rising prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period

Incidence of clostridium difficile infection has been witnessing an increase in the recent past, due to clostridium difficile infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), 2015, around half a million people in the U.S. suffer from clostridium difficile infection in a year. Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016 showed significant incidence of clostridium difficile infection in China. Furthermore, according to Canadian Antimicrobial Resistance Surveillance System 2017 Report, clostridium difficile infection may be a consequence of commonly prescribed antibiotics for unrelated infections. According to Organization for Economic Co-operation and Development (OECD), 2015, antibiotic resistant bacteria are highly prevalent in G7 countries. This high presence of antibiotic resistant bacteria may lead to increasing incidence of the infection, which in turn is expected to aid in growth of the global clostridium difficile diagnostics and treatment market.

The global clostridium difficile diagnostics and treatment market was valued at US$ 1,272.2 million in 2016 and is expected to witness a robust CAGR of 8.2% over the forecast period (2017–2025).

Highlights of the report:

1. A complete backdrop analysis, which includes an assessment of the parent market

2. Important changes in market dynamics

3. Market segmentation up to the second or third level

4. Historical, current, and projected size of the market from the standpoint of both value and volume

5. Reporting and evaluation of recent industry developments

6. Market shares and strategies of key players

7. Emerging niche segments and regional markets

8. An objective assessment of the trajectory of the market

9. Recommendations to companies for strengthening their foothold in the market

Key Questions Answered

– What is the size and CAGR of the global Clostridium Difficile Diagnostics and Treatment market?

– What are the key driving factors of the most profitable regional market?

– Which are the leading segments of the global Clostridium Difficile Diagnostics and Treatment market?

– How will the global Clostridium Difficile Diagnostics and Treatment market advance in the coming years?

– What are the main strategies adopted in the global Clostridium Difficile Diagnostics and Treatment market?

– What is the nature of competition in the global Clostridium Difficile Diagnostics and Treatment market?

– What growth impetus or acceleration market carries during the forecast period?

– Which region may hit the highest market share in the coming era?

– What trends, challenges, and barriers will impact the development and sizing of the Global Clostridium Difficile Diagnostics and Treatment Market?

The Clostridium Difficile Diagnostics and Treatment Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

LIMITED TIME OFFER - Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Apply Promo Code "CMIFIRST1000" And Get an Instant Discount Of USD 1000

Buy Now This Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1499

Reasons for Buying this Report

This Clostridium Difficile Diagnostics and Treatment Market report provides pin-point analysis for changing competitive dynamics.
It provides a forward-looking perspective on different factors driving or restraining Market growth.
It provides a six-year forecast assessed on the basis of how the Market is predicted to grow.
It helps in understanding the key product segments and their future.
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.